“For many healthcare systems, the rapid adoption of connected medical device technology expands the potential cyber-attack surface, and creates a significant cybersecurity gap, therefore making it difficult to scale device security,” said Shankar Somasundaram, Asimily’s founder and CEO. “All of our clients will now have access to a world-class service portfolio that provides for the management and oversight of a hospital's entire life-cycle of connected medical devices and clinical technologies. This management and oversight include safety, cybersecurity, asset and risk management, technical support and financial stewardship.”
With the strategic partnership in place, Crothall and its clients will have laser sharp visibility into the client’s connected medical device profiles. Asimily’s machine learning will then assess risk, prioritize actions and allow for the development of mitigation strategies to reduce security vulnerabilities.
“Our partnership will enhance Crothall’s medical device security offering with Asimily’s technical expertise in medical device security while Asimily will have the opportunity to access Crothall’s on-site expertise for identified vulnerabilities and risk mitigation,” said Jim Cheek, president of Crothall HTS.
This offering will allow Crothall and its clients to manage a full spectrum of capabilities: asset utilization; U.S. Food and Drug Administration recall notification; device vendor tracking; and user defined policy alerts in the environment. The partnership enhances the abilities of Crothall and its clients to manage devices from initial capital planning to end-of-life.